Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01738139
Title Ipilimumab and Imatinib Mesylate in Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

gastrointestinal stromal tumor

Advanced Solid Tumor

Therapies

Imatinib + Ipilimumab

Age Groups: senior | child | adult
Covered Countries USA

Additional content available in CKB BOOST